Current NDC auxiliary source row compounder:475

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5600
Product Ndc: 26436-5600
Product Ndc Digits: 264365600
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Testosterone Cypionate 20mg/mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Testosterone Cypionate 20mg/mL
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: TESTOSTERONE CYPIONATE
Active Ingredients Info: 20 mg/1 mL
History Active Ingredients Raw: TESTOSTERONE CYPIONATE
History Active Ingredients Info Raw: 20 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: CIII
Package Ndc Raw: 26436-5600-5
Package Ndc: 26436-5600-5
Package Ndc Digits: 2643656005
Package Ndc11: 26436560005
Package Description: 5 mL in 1 VIAL, MULTI-DOSE (26436-5600-5)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:475
Source Row Number: 475
Source Row Hash: bd29976135c71293af7aa06bdcacf482a4869f84d8dd5c7d3d26400535ea8f8c
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR",
    "PRODUCTNDC": "26436-5600",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "TESTOSTERONE CYPIONATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "26436-5600-5",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Testosterone Cypionate 20mg/mL",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Testosterone Cypionate 20mg/mL",
    "PACKAGEDESCRIPTION": "5 mL in 1 VIAL, MULTI-DOSE (26436-5600-5) ",
    "ACTIVEINGREDIENTSINFO": "20 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:475
Source Row Number: 475
Status Scope: package
Lookup Ndc: 26436-5600-5
Lookup Ndc Digits: 2643656005
Product Ndc: 26436-5600
Product Ndc Digits: 264365600
Package Ndc: 26436-5600-5
Package Ndc Digits: 2643656005
Package Ndc11: 26436560005
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: bd29976135c71293af7aa06bdcacf482a4869f84d8dd5c7d3d26400535ea8f8c
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20